What is the Korean Drug Co. Ltd. stock price forecast?

Korean Drug Co. Ltd. is currently trading at ₩3,470. View real-time AI analysis on Alpha Lenz.

What is Korean Drug Co. Ltd. insider trading activity?

View the latest insider trading data for Korean Drug Co. Ltd. on Alpha Lenz.

What is Korean Drug Co. Ltd.'s P/E ratio?

Korean Drug Co. Ltd.'s P/E ratio is 5.9.

Korean Drug Co. Ltd.

KRX · 014570

₩3,470+35(+1.02%)Market closed

Ask about Korean Drug Co. Ltd.'s future dividend policy...

Alpha Chat Insight

“Korean Drug Co. Ltd. trades at a P/E of 5.9 (undervalued) with solid ROE of 8.1%.”

Ask for details →

Company Overview

Korean Drug Co. Ltd. is a pharmaceutical company based in South Korea, primarily engaged in the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company's portfolio includes prescription drugs, over-the-counter medications, and health supplements. Korean Drug Co. Ltd. operates in various therapeutic areas, including cardiovascular health, respiratory conditions, and the central nervous system, catering to an extensive healthcare market. It serves hospitals, healthcare providers, and pharmacies, both domestically and internationally. In the financial market, Korean Drug Co. Ltd. plays a significant role by contributing to the advancement of medical treatments and benefiting public health through innovative healthcare solutions.

CEO박해룡, 박상훈 (각자대표)

Websitehttps://www.nicepharma.com

SectorHealthcare

IndustryDrug Manufacturers - General

Company Statistics

FY 2025

Profile

₩38,170,000,000Market Cap

₩62,508,834,670Revenue

11.00MShares Out

0Employees

Margins

42.55%Gross

15.92%EBITDA

11.06%Operating

12.47%Pre-Tax

10.42%Net

Valuation

5.86P/E

0.46P/B

0.61EV/Sales

3.35EV/EBITDA

3.02P/FCF

Growth (CAGR)

-7.89%Rev 3Yr

-1.32%Rev 5Yr

-21.57%Op Inc 3Yr

-8.94%Op Inc 5Yr

-18.00%Net Inc 3Yr

-2.42%Net Inc 5Yr

Returns

7.11%ROA

8.08%ROE

8.52%ROIC

Financial Health

₩4,885,587,630Cash & Cash Equivalents

₩6,361,099,870Net Debt

13.54%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Korean Drug Co. Ltd. trades at a P/E of 5.9 (undervalued) with solid ROE of 8.1%.”

Ask for details →

Frequently Asked Questions

Korean Drug Co. Ltd. (ticker: 014570) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - General). Market cap is $38.2B.

The current price is ₩3,470 with a P/E ratio of 5.86x and P/B of 0.46x.

ROE is 8.08% and operating margin is 11.06%. Annual revenue is $62.5B.